Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial
- Resource Type
- Article
- Source
- The Lancet; November-December 2021, Vol. 398 Issue: 10315 p1984-1996, 13p
- Subject
- Language
- ISSN
- 01406736; 1474547X